StreetInsider.com News Articles

Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam

Wed, 12 Mar 2025 07:59:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces that:

All resolutions proposed at its Extraordinary General Meeting held today (the “EGM”) were duly passed with overwhelming support (over 95% in favour).
Effective immediately, BenevolentAI has merged into Osaka Holdings S.à r.l. (“Osaka Holdings”). As a result, the original BenevolentAI entity has ceased to exist.
Simultaneously, Osaka Holdings has converted its legal form from an S.à r.l. to an S.A., and has adopted the name BenevolentAI.
BenevolentAI shares will be delisted from Euronext Amsterdam effective 13 March 2025.
The adjusted warrant

Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam

Wed, 12 Mar 2025 07:59:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces that:

All resolutions proposed at its Extraordinary General Meeting held today (the “EGM”) were duly passed with overwhelming support (over 95% in favour).
Effective immediately, BenevolentAI has merged into Osaka Holdings S.à r.l. (“Osaka Holdings”). As a result, the original BenevolentAI entity has ceased to exist.
Simultaneously, Osaka Holdings has converted its legal form from an S.à r.l. to an S.A., and has adopted the name BenevolentAI.
BenevolentAI shares will be delisted from Euronext Amsterdam effective 13 March 2025.
The adjusted warrant

Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam

Wed, 12 Mar 2025 07:59:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces that:

All resolutions proposed at its Extraordinary General Meeting held today (the “EGM”) were duly passed with overwhelming support (over 95% in favour).
Effective immediately, BenevolentAI has merged into Osaka Holdings S.à r.l. (“Osaka Holdings”). As a result, the original BenevolentAI entity has ceased to exist.
Simultaneously, Osaka Holdings has converted its legal form from an S.à r.l. to an S.A., and has adopted the name BenevolentAI.
BenevolentAI shares will be delisted from Euronext Amsterdam effective 13 March 2025.
The adjusted warrant

Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam

Wed, 12 Mar 2025 07:59:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces that:

All resolutions proposed at its Extraordinary General Meeting held today (the “EGM”) were duly passed with overwhelming support (over 95% in favour).
Effective immediately, BenevolentAI has merged into Osaka Holdings S.à r.l. (“Osaka Holdings”). As a result, the original BenevolentAI entity has ceased to exist.
Simultaneously, Osaka Holdings has converted its legal form from an S.à r.l. to an S.A., and has adopted the name BenevolentAI.
BenevolentAI shares will be delisted from Euronext Amsterdam effective 13 March 2025.
The adjusted warrant

Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam

Wed, 12 Mar 2025 07:59:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces that:

All resolutions proposed at its Extraordinary General Meeting held today (the “EGM”) were duly passed with overwhelming support (over 95% in favour).
Effective immediately, BenevolentAI has merged into Osaka Holdings S.à r.l. (“Osaka Holdings”). As a result, the original BenevolentAI entity has ceased to exist.
Simultaneously, Osaka Holdings has converted its legal form from an S.à r.l. to an S.A., and has adopted the name BenevolentAI.
BenevolentAI shares will be delisted from Euronext Amsterdam effective 13 March 2025.
The adjusted warrant

Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam

Wed, 12 Mar 2025 07:59:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces that:

All resolutions proposed at its Extraordinary General Meeting held today (the “EGM”) were duly passed with overwhelming support (over 95% in favour).
Effective immediately, BenevolentAI has merged into Osaka Holdings S.à r.l. (“Osaka Holdings”). As a result, the original BenevolentAI entity has ceased to exist.
Simultaneously, Osaka Holdings has converted its legal form from an S.à r.l. to an S.A., and has adopted the name BenevolentAI.
BenevolentAI shares will be delisted from Euronext Amsterdam effective 13 March 2025.
The adjusted warrant

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

Thu, 06 Feb 2025 01:00:00 -0400

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces:

Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to a private company structure.
Simplification of the Company’s share structure and related instruments that reduces the current complexity and administrative overheads.
The convening notice for the Extraordinary General Meeting (the “EGM”), the proxy form and the documents related to the items on the EGM

BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission

Wed, 11 Dec 2024 01:00:00 -0400

Changes mark a return to BenevolentAI’s foundational strengths
Initiates significant organisational restructuring
Announces intention to evaluate delisting from Euronext Amsterdam

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI (“the Company”), a pioneer in integrating artificial intelligence with biopharmaceutical development, today unveils a major strategic overhaul to return the Company to its founding TechBio mission. These changes mark a return to the Company’s foundational strengths, refocusing efforts on core technologies and innovation to better develop transformative drug discovery and development solutions. In parallel, and to support this, the Company has initiated significant organisational and budgetary changes that extend the Company’s runway into 2027. As

BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission

Wed, 11 Dec 2024 01:00:00 -0400

Changes mark a return to BenevolentAI’s foundational strengths
Initiates significant organisational restructuring
Announces intention to evaluate delisting from Euronext Amsterdam

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission

Wed, 11 Dec 2024 01:00:00 -0400

Changes mark a return to BenevolentAI’s foundational strengths
Initiates significant organisational restructuring
Announces intention to evaluate delisting from Euronext Amsterdam

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission

Wed, 11 Dec 2024 01:00:00 -0400

Changes mark a return to BenevolentAI’s foundational strengths
Initiates significant organisational restructuring
Announces intention to evaluate delisting from Euronext Amsterdam

LONDON--(BUSINESS WIRE)-- Regulatory News:

BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission

Wed, 11 Dec 2024 01:00:00 -0400

Changes mark a return to BenevolentAI’s foundational strengths
Initiates significant organisational restructuring
Announces intention to evaluate delisting from Euronext Amsterdam

LONDON--(BUSINESS WIRE)-- Regulatory News: